Zoetis Inc. recently started the construction of a combined global manufacturing and supply and research and development centre in Suzhou, China.

The new facility will focus on development and production of quality vaccines for swine, cattle, fish and companion animals that help protect against the strains of diseases prevalent in China.

Zoetis also marked the opening of an interim research and development facility nearby in Suzhou where the company’s PHARMAQ business will begin to develop vaccines for the farmed fish industry in China; the first such R&D centre established by a multinational company to concentrate on aquaculture in mainland China.

The planned vaccine research and development (R&D) centre in Suzhou will expand and strengthen the innovation underway at the Zoetis R&D laboratory in Beijing, which opened in 2015.